EU Liaison To CIR Among Changes Planned To Strengthen Panel
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic Ingredient Review Expert Panel plans to add a representative from the European Union as part of a program designed to strengthen the CIR process. The EU liaison is expected to improve communication regarding international harmonization and help FDA to implement the harmonization requirements of the FDA Modernization Act.
You may also be interested in...
CIR Support For Ingredient Immune, Hormonal Effects Screening Urged
Cosmetic ingredient screening data on immune suppression and enhancement effects on skin should become a more regular element of safety assessments conducted by the Cosmetic Ingredient Review Expert Panel in the future, outgoing panelist Arnold Schroeter, MD, said at a CIR meeting in Washington, D.C. June 4-5.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program